AKT1 and non-proliferative diabetic retinopathy: In NPDR, this peptide can reduce NF-κB, the inflammasome and proinflammatory factors to play an anti-inflammatory role, and it can promote cell survival by increasing anti-apoptotic proteins and activating the GLP-1R/AKT/GSK-3β signaling pathway [200].